Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MT-ND2 pseudogene 8 (MTND2P8) is classified as a pseudogene of the mitochondrial gene MT-ND2 in Homo sapiens[2][4]. Pseudogenes typically arise from duplication or retrotransposition events and do not produce functional proteins. There is no evidence that MTND2P8 encodes any protein, nor is it directly involved in mitochondrial function, disease, or targeted by therapeutic agents. While differential expression of certain mtDNA pseudogenes has been observed in disease contexts (such as Alzheimer's disease), including other MT-ND2 pseudogene variants, these associations are not specific to MTND2P8 and are not clearly causal or mechanistically compelling[5]. MTND2P8 is not a receptor, enzyme, or transporter, and should not be considered a drug target. The functional MT-ND2 gene encodes a core subunit of mitochondrial NADH:ubiquinone oxidoreductase (complex I), which is essential for cellular respiration, but MTND2P8 does not share these properties[1][3][4]. Summary of Findings: - MTND2P8 is a pseudogene and is not a functional molecule for therapeutic targeting. - No established aliases other than full descriptive name and abbreviation. - No molecular family associations beyond "pseudogene". - No role in biological function or as a drug target. - No links to drug mechanisms, biomarkers, or safety challenges. - There may be some research interest in differential pseudogene expression in brains of Alzheimer's patients, but the literature does not support MTND2P8 as a causal or actionable target for disease intervention[5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MT-ND2 pseudogene 8 (MTND2P8).